More delays in GTG-Applera case
Monday, 05 December, 2005
Two deadlines have come and gone, and a third expires today for Melbourne gene-testing company Genetic Technologies (ASX:GTG; NASDAQ:GENE) and US firm Applera, who were due to announce a resolution of their licensing dispute in California today.
GTG has been pursuing its US rival in the US District Court of Northern California for a licensing fee and royalties for its patented technologies, which uses 'junk DNA' markers to identify haplotypes associated with disease.
The case was originally due to be resolved by a court-sanctioned agreement on November 9, but the companies postponed their execution of a binding settlement, and licence and supply issues until November 25. When November 25 passed, Judge Joseph Spero approved a requested delay until December 5.
After a telephone conference with both parties, Judge Spero has now granted a further extension to Wednesday, December 8, and ordered lawyers and company representatives to attend a further settlement conference in San Francisco.
GTG said the delay was "a positive development in the progress of this matter
Oxytocin analogue treats chronic abdominal pain
Researchers have developed a new class of oral painkillers to suppress chronic abdominal pain,...
'Low-risk' antibiotic linked to rise of dangerous superbug
A new study has challenged the long-held belief that rifaximin — commonly prescribed to...
Robotic hand helps cultivate baby corals for reef restoration
The soft robotic hand could revolutionise the delicate, labour-intensive process of cultivating...
